<DOC>
	<DOCNO>NCT02210871</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate pharmacokinetics ( exposure trial drug body ) , safety tolerability single injection semaglutide subject mild , moderate severe hepatic impairment compare subject normal hepatic function .</brief_summary>
	<brief_title>Investigating Pharmacokinetics , Safety Tolerability After Single Subcutaneous Injection Semaglutide Subjects With Mild , Moderate Severe Hepatic Impairment Compared Subjects With Normal Hepatic Function</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female , age least 18 year time signing informed consent Body mass index ( BMI ) 18.540.0 kg/m^2 ( inclusive ) Only subject hepatic impairment ( mild , moderate severe ) : A diagnosis cirrhosis due parenchymal liver disease , classify ChildPugh grade A , B C assess investigator confirm documented medical history , physical examination least one following : hepatic ultrasound , computerise axial tomography ( CT ) scan , magnetic resonance imaging ( MRI ) , and/or liver biopsy Only subject normal hepatic function : Subjects judge good general health base physical examination , medical history , ECG , vital sign , result biochemistry , coagulation , haematology test urinalysis perform screen visit , judge investigator Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method throughout trial include followup period ( adequate contraceptive measure require local regulation practice ) Uncontrolled hypertension ( define systolic blood pressure equal 180 mmHg and/or diastolic blood pressure equal 100 mmHg ) . If whitecoat hypertension suspect screen visit repeat measurement screen visit allow Mental inability , unwillingness language barrier preclude adequate understanding compliance trial procedure Donation blood plasma past month excess 400 mL within 3 month precede screening , surgery trauma 400 mL blood loss within 3 month precede screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>